Taro Pharmaceutical Industries Ltd (TARO)
42.21
-0.02
(-0.05%)
USD |
NYSE |
Apr 24, 16:00
42.21
0.00 (0.00%)
After-Hours: 20:00
Taro Pharmaceutical Industries Cash from Financing (TTM): 0.00 for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -6.615M |
| March 31, 2022 | -24.93M |
| December 31, 2021 | -45.89M |
| September 30, 2021 | -49.13M |
| June 30, 2021 | -42.52M |
| March 31, 2021 | -24.20M |
| December 31, 2020 | -3.40M |
| September 30, 2020 | -26.98M |
| June 30, 2020 | -26.98M |
| March 31, 2020 | -26.98M |
| December 31, 2019 | -43.48M |
| September 30, 2019 | -556.44M |
| June 30, 2019 | -564.19M |
| March 31, 2019 | -588.85M |
| December 31, 2018 | -624.26M |
| September 30, 2018 | -98.97M |
| June 30, 2018 | -123.15M |
| March 31, 2018 | -106.99M |
| December 31, 2017 | -80.11M |
| Date | Value |
|---|---|
| September 30, 2017 | -94.70M |
| June 30, 2017 | -170.90M |
| March 31, 2017 | -294.90M |
| December 31, 2016 | -279.16M |
| September 30, 2016 | -255.51M |
| June 30, 2016 | -147.60M |
| March 31, 2016 | -15.34M |
| December 31, 2015 | -6.107M |
| September 30, 2015 | -10.97M |
| June 30, 2015 | -10.94M |
| March 31, 2015 | -10.92M |
| December 31, 2014 | -10.79M |
| September 30, 2014 | -204.25M |
| June 30, 2014 | -203.78M |
| March 31, 2014 | -203.46M |
| December 31, 2013 | -202.02M |
| September 30, 2013 | -7.204M |
| June 30, 2013 | -6.823M |
| March 31, 2013 | -3.326M |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -4.048M |
| September 30, 2011 | -72.95M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-564.19M
Minimum
Jun 2019
--
Maximum
Sep 2022
-75.88M
Average
-24.93M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
| InspireMD Inc | 37.53M |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | 2.899M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |